Our Portfolio.

Inkef has backed more than 45 companies in healthcare and technology. We have supported and continue to actively support companies with financing, business strategy, insights to help shape their future.

Castor

Castor is a medical software development company based in Amsterdam, the Netherlands. Founded in 2011 by Derk Arts, their signature programme is a cloud-based electronic data capture platform which enables researchers to easily capture high-quality, reusable medical data. Now with 30k+ users, 2,500+ studies, servers in 3 countries and funding by INKEF Capital, Castor is well on their way to getting their platform used by medical researchers and institutions worldwide.

View this case

Withlocals

Withlocals is an online marketplace for travelers and locals to connect. The platform lets locals create personal and unique travel experiences for travelers, earn their fair share by doing what they love, and gives travelers authentic experiences and stories to share with their friends and families. All this while changing minds and hearts along the way.

View this case

ViCentra

ViCentra has developed an insulin pump for diabetes patients. The company aims to create a user-friendly device designed to provide diabetes patients with greater freedom in their day-to-day lives.

Bloomon

Bloomon, is a subscription-based flower delivery service based in Amsterdam, was founded in 2014 by Patrick Hurenkamp and Koen Thijssen. Dubbed as the ‘Netflix of Flowers’ by the Financial Times, Bloomon’s goal is to bring bespoke bouquets from grower to consumer in the fastest way possible by cutting out the traditional supply chain. Headquartered in Amsterdam, it now has international offices in Berlin, London and Taiwan.

View this case

To create break through businesses in technology and healthcare.

Aside from the core investment team, INKEF leverages a network of global industry experts. They are thought leaders in their fields and, sometimes, they can even predict the future better than we can. They make us smarter, and we hope they can help you too. We also foster open dialogue between our portfolio companies so that the entrepreneurs we back can exchange learnings and avoid common pitfalls.

All
Exited
Healthcare
Technology
Privacy Policy Copyright 2022 © Inkef Capital
Category healthcare

Precirix

Precirix is a private, clinical-stage biopharmaceutical company founded in 2014 as a spin-off from the VUB, dedicated to extending and improving the lives of cancer patients by designing and developing precision radiopharmaceuticals, using camelid single-domain antibodies labelled with radioisotopes. The company has a broad pipeline with one product candidate in a Phase I/II clinical trial and two in advanced preclinical stage. Research on multiple isotopes, linker technology and combination therapies further expand the platform. Precirix’s technology also allows for a theragnostic approach, where patients can be selected using a low dose/imaging version of the product, followed by a therapeutic dose for treatment.
Category healthcare

TargED

TargED Biopharmaceuticals B.V. is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis. TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis. The lead compound is Microlyse, which is currently under development for thrombotic thrombocytopenic purpura (TTP) and Acute Ischemic Stroke (AIS). The objective is to accelerate thrombolysis in all forms of thrombosis, irrespective of the thrombus composition.
Category healthcare

Ambagon Therapeutics

Ambagon Therapeutics is a biotechnology company pioneering methods to unlock intrinsically disordered protein targets using small molecules. Ambagon applies deep knowledge of 14-3-3 proteins and a proprietary suite of drug discovery tools to create molecular glues that stabilize 14-3-3:target complexes. These molecular glue stabilizers amplify native biology to restore or inhibit target function, potentiate target activity, or promote or block target degradation. Ambagon’s initial focus is on oncology, with five programs in discovery. It has locations in San Carlos, California, and Eindhoven, the Netherlands.
Category healthcare

Cardior

Cardior Pharmaceuticals is a leading clinical-stage biopharmaceutical company pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart. Cardior’s therapeutic approach uses distinctive non-coding RNAs as an innovative platform for addressing the root causes of cardiac dysfunctions. The company aspires to bring transformative therapeutics and diagnostics to patients and thereby make a lasting impact on the treatment of cardiac diseases worldwide
Category

Draupnir Bio

Draupnir Bio is a Danish biotechnology company developing small molecule therapeutics to transform the treatment of heart disease, based on proprietary structural insights and the biology of Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9), a protein that enables a key step in the control of plasma low density lipoprotein cholesterol (LDLC) levels. The company was founded in 2017 as a spin-out from Aarhus University, Denmark, and the Max Planck Society, Germany. Backed by a syndicate of leading European investors, in 2019 Draupnir Bio completed a Series A funding round, raising €30 million Euros with participation from Gilde Healthcare Partners, Inkef Capital, Novo Seeds and High-Tech Gründerfonds. The company is headquartered in Copenhagen, with research operations centered in Aarhus, Denmark.
Category technology

Sentinels

Sentinels is an intelligent transaction monitoring solution dedicated to data-driven compliance for the financial industry. With a team of more than 20 in-house engineers, Sentinels’ pragmatic-AI approach has a proven track record in improving compliance outcomes. Its secure cloud-based offering ensures a high level of customer trust and meets constantly changing regulatory requirements.
Category healthcare

Anavo Therapeutics

Anavo Therapeutics is the first biotech company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. With world-leading scientific expertise in phosphatase-driven disease biology and drug discovery, Anavo is working to unlock the full potential of phosphatase-targeted allosteric modulators for oncology applications.
Category technology

ChannelEngine

With a single powerful integration, ChannelEngine connects seller systems to international marketplaces and sales channels while optimizing sales, minimizing time, and maximizing profit and reach. It offers brands, distributors, and retailers automated order and return systems, an advanced management suite and rich partner ecosystem, to bring their sales to the next level.
Category technology

Lengoo

Lengoo makes AI work for translation. As a language tech company, we supercharge human translators with AI technology. We custom-train neural machine translation models for our clients using their own data. Our language models learn all about the enterprise’s individual way to communicate and produce high-quality machine translation. The feedback of human translators constantly improves our language models and allows us to provide professional translations 3-6 times faster and 50% cheaper than traditional providers. We support global enterprises like NI (National Instruments), Sixt, Sunrise Communications, KIOXIA, or Michelin. Find out more at www.lengoo.com
Category technology

Silverflow

Silverflow is a payments technology company, founded by online payments industry veterans, with the mission to accelerate technological innovation in the complex payments value chain. Silverflow’s cloud-based platform provides a state-of-the-art upgrade and direct access to the card networks for payment services providers, merchants and acquirers. Its intuitive product and scalable technology provides value, creates efficiencies, and drives new opportunities for all.
Category healthcare

Salvia BioElectronics

Salvia is developing a medical device for chronic migraine. The company is working on a new neuromodulation approach, to provide relief for patients who suffer from debilitating headaches more than 15 days per month.
Category healthcare

VarmX

VarmX is a spin out of Leiden University Medical Center. VarmX lead program is an innovative antidote for life-threatening bleeding in the ever growing number of patients under Factor Xa anticoagulant treatment. VarmX is also developing new technologies to address risks from new classes of anticoagulants.
Category technology

Happeo

Happeo is the community-powered employee communications platform that Internal Communications, HR and leaders use to align and engage talent. It is the tool they need to create a high-performing digital culture – fueled by a strong employee community. Happeo serves customers in every continent and is on a mission to change the way companies communicate internally.
Category exited technology

GitLab

GitLab Inc. is a company based on the GitLab open-source project. GitLab is an application to code, test, and deploy code together. It provides Git repository management with fine grained access controls, code reviews, issue tracking, activity feeds, wikis, and continuous integration.
Category technology

Quantum Motion

Founded in 2017, Quantum Motion is developing silicon spin-based qubit architectures which are compatible with standard CMOS fabrication and so provide easier scaling to thousands and millions of qubits. This is particularly important to allow the qubit redundancy that is required to make a fully functional, fault tolerant, quantum computer, but also gives the near-term opportunity of easy integration in a hybrid quantum/classical computer.
Category healthcare

QurAlis

QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. QurAlis scientist are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.
Category technology

Remote

Remote is a leader in building, managing and supporting global, remote-first workforces. Using Remote’s futureforward HR platform, businesses can hire and retain the world’s best talent – regardless of where that talent is based. With expert team members located in more than 60 countries, Remote provides all the tools and support companies need to manage onboarding, payroll, benefits, relocation and other services for their teams. Remote- was founded in 2019 by Job van der Voort and Marcelo Lebre. In 2021, Remote was named one of Inc.’s Best Workplaces, named a Leader in Multi-Country Payroll by G2, and received Comparably’s awards for Best Company for Diversity and Best Company for Happiness. For more information, visit https://remote.com/
Category healthcare

iOnctura

iOnctura BV, headquartered in Geneva, Switzerland, was founded in June 2017 as a spin out from Merck and funded by M Ventures. It is a clinical stage biotechnology company developing a pipeline of next generation, differentiated molecules that are at the forefront of pioneering new therapies for the treatment of cancer. Each of iOnctura’s programs harness the combined effect of immune-mediated and direct anti-tumour activity and aim to deliver molecules with superior clinical efficacy and safety in oncology. The company’s lead program, IOA-244, will enter the clinic in Q1 2020. The study is aimed to clinically demonstrate for the first time that a highly selective PI3Kδ inhibition not only drives an immune-mediated response but also a direct anti-tumoural effect in a stratified patient population across multiple solid tumour indications. The Company’s second molecule is a novel autotaxin (ATX) inhibitor at IND stage for patients with solid tumours burdened with cancer-associated fibrosis. For more information, please visit www.ionctura.com
Category technology

Urban Sports Club

Urban Sports Club offers a flexible flat-rate sports membership. The mission is to help people lead a healthy and active lifestyle. Club members can choose from 50+ activities – ranging from classic gym workout, swimming, yoga, or bouldering, to team sports and lots more – and more than 7,000 partner venues in Germany, France, Italy, Spain and Portugal. Variety, flexible conditions as well as team sports and wellness are offered both for private customers and companies. Urban Sports GmbH was founded in 2012 by Moritz Kreppel and Benjamin Roth in Berlin, Germany. After two years of bootstrapping, the company secured an early-stage financing in 2015 and went on to acquire four of its German competitors. In December 2016, the former competitor Somuchmore joined the German market leader; FITrate joined in January 2018 and in December INTERFIT.
Category technology

Provable Labs

Maximum Liquidity with Minimal Disclosure. Provable labs applies secrecy-preserving, secure multi-party computation technology to build trading platforms that allow participants to express their positions and find liquidity without the risk of price slippage.
Category healthcare

Calypso

Calypso Biotech is an immunotherapy biotech company, spin-off from Merck Serono, that discovers and develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs. Calypso Biotech’s lead program, CALY-002, is a best-in-class therapeutic antibody against interleukin-15 (IL-15).
Category healthcare

Onward

ONWARD is creating technologies to improve the movement, independence, and health of people with spinal cord injury. The company is based in Eindhoven, NL and Lausanne, CH and has a growing presence in Boston, US. Two of ONWARD’s technologies have been awarded Breakthrough Device Designation by the FDA.
Category exited healthcare technology

Aidence

Aidence is a company that is bringing the full potential of Artificial Intelligence into the hands of medical professionals in medical imaging and disease detection. Aidence combines data scientists, deep-learning developers and radiologists. The first product of Aidence is the AI platform Veye, a highly accurate and clinically approved assistant for medical image analysis.
Category technology

Polarsteps

Founded in 2015, Polarsteps is used by over 1 million travelers in 180+ countries to track their trips and share them in real time with their closest friends and family. Polarsteps wants to inspire and connect people through travel. It believes that the best way to do that is by creating a place where the entire travel experience is combined within one platform. From the very first inspiration on where to go, to remembering your trip years after it has ended. The Amsterdam-based startup is therefore building the place to go to for travelers that want to plan, track and remember their adventures around the globe.
Category healthcare technology

Castor

Castor is a medical software development company based in Amsterdam, the Netherlands. Founded in 2011 by Derk Arts, their signature programme is a cloud-based electronic data capture platform which enables researchers to easily capture high-quality, reusable medical data. Now with 30k+ users, 2,500+ studies, servers in 3 countries and funding by INKEF Capital, Castor is well on their way to getting their platform used by medical researchers and institutions worldwide.
Read more
Category technology

Withlocals

Withlocals is an online marketplace for travelers and locals to connect. The platform lets locals create personal and unique travel experiences for travelers, earn their fair share by doing what they love, and gives travelers authentic experiences and stories to share with their friends and families. All this while changing minds and hearts along the way.
Read more
Category healthcare

Comet Therapeutics

CoEnzyme A (CoA) is essential to numerous cellular processes including the metabolism of fatty acids, amino acids and sugars, the regulation of gene expression, and the proper functioning of the TCA cycle and mitochondrial health, which generates the energy all cells need to live. There are many genetic, rare metabolic disorders that are CoA related. In addition, dysregulated CoA metabolism is a key factor in diseases as diverse as cancer, fatty liver and neurological disorders. While CoA has been in biochemistry textbooks for 70 years, there are no therapies to restore dysregulated coenzyme A metabolism. Comet Therapeutics addresses these profound unmet medical needs with its CoEnzyme Metabolism (CoMET™) Platform.
Category healthcare

NMD Pharma

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders. Research by the founders working on the neuromuscular junction identified an approach that improves neuromuscular transmission in a way that is potentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.
Category technology

Cashforce

Founded in 2012, Cashforce products help large enterprises with getting more accurate cash flow forecasts and with managing working capital at a company-wide level while also providing granular insights down to the transaction level by integrating with existing ERP and TMS implementations.
Year Of Investment 2015
Category technology

EclecticIQ

EclecticIQ’s mission is to restore balance in the fight against cyber adversaries. Its flagship product EclecticIQ Threat Intelligence Platform enables operationalization of security information exchange, empowers collaborative analyst workflow and ensures timely integration of cyber threat intelligence detection, prevention and response capabilities. EclecticIQ applies best practices from the intelligence world in a cybersecurity setting and is currently selling to large enterprises and MSSPs.
Category exited technology

GeoPhy

Co-founded in 2014 by Teun van den Dries (CEO) and Sander Mulders (CTO), GeoPhy provides data-driven valuations and analytics for commercial real estate (CRE). The platform uses supervised machine learning and big data to create insights that help drive acquisition due diligence, portfolio monitoring, and site selection for institutional lenders and investors in the real estate and financial sector. GeoPhy is headquartered in Delft, the Netherlands, with offices in New York, London and Kaunas (Lithuania).
Category healthcare

ViCentra

ViCentra has developed an insulin pump for diabetes patients. The company aims to create a user-friendly device designed to provide diabetes patients with greater freedom in their day-to-day lives.
Category technology

Shapeways

Shapeways is the world’s leading 3D printing service and marketplace, empowering designers to bring amazing products to life. By giving anyone the ability to quickly and affordably turn ideas from digital designs into real products, Shapeways is fundamentally changing how products are made and by whom. Headquartered in Manhattan, Shapeways also has factories and offices in Eindhoven, Long Island City and Seattle.
Category healthcare

Scenic Biotech

Scenic Biotech BV is a spinout company of the Netherlands Cancer Institute (NKI) and Oxford University, based in Amsterdam, The Netherlands. It is Scenic Biotech’s mission to harness genetic modifiers to combat disease. The company was founded by Prof Thijn Brummelkamp and Prof Sebastian Nijman.
Category technology

NPEX

NPEX is a fully licensed SME-Exchange in the Netherlands. Unlike traditional exchanges, this auction-based platform enables investors to set a minimum ask price and define the time limits for the bidding process. NPEX focuses on small and medium-sized enterprises looking for growth capital of € 500,000 and higher.
Category technology

Robin

Robin – short for Radar Observation of Bird INtensity” – develops innovative radar systems for tracking and identifying birds. With unique access to the world’s most advanced bird radar technology, Robin radar aims to increase flight safety for humans, bats and birds.
Category healthcare

Audion

Audion Therapeutics is a private biopharmaceutical company dedicated to the discovery, development and commercialization of drugs and delivery technologies for the treatment of hearing loss.
Category healthcare

InteRNA

InteRNA is a Dutch biotechnology company specializing in the development of RNA therapeutics for the treatment of cancer. InteRNA is a true pioneer in the discovery and creation of a new class of drugs, called microRNAs (miRNAs). The company proprietary technology platform has been developed for discovery and validation of miRNA-based drug candidates for the simultaneous regulation of multiple targets.
Category technology

Aito

Aito is a user interface innovator that believes “a product is desirable when its interaction is pleasurable.” Headquartered in Amsterdam with a Research Department in Helsinki, Aito’ breakthrough piezoelectric sensing technology is well on its way to becoming the leader in premium user interfaces. Aito’s products are currently licensed worldwide, with a strong focus in Asia.
Category technology

Crowdynews

Crowdynews is a social media curation platform that gathers and filters relevant social media content and posts it real time next to topical, popular stories. The service provides publishing organizations with new revenue streams and augments content with social media sources such as Twitter, Facebook, YouTube, Instagram and Vimeo. The application is available in 25 languages and is active globally with offices in Groningen, Boston and Singapore.
Category healthcare

Corporis Medical

Corporis Medical manufacturers so-called ‘APM devices’, a revolutionary new blood-flow measuring device for bowel cancer surgery. After the bowel is removed, surgeons create a new bowel connection, called ‘the anastomosis’. This anastomosis is prone for leakage & complications if inadequately supplied of oxygenated blood. The APM device measures blood flow at the anastomosis in a revolutionary new way during surgery. Preventing these complications of the anastomosis will decrease postoperative deaths, intensive care stay & cost.
Category exited technology

Bloomon

Bloomon, is a subscription-based flower delivery service based in Amsterdam, was founded in 2014 by Patrick Hurenkamp and Koen Thijssen. Dubbed as the ‘Netflix of Flowers’ by the Financial Times, Bloomon’s goal is to bring bespoke bouquets from grower to consumer in the fastest way possible by cutting out the traditional supply chain. Headquartered in Amsterdam, it now has international offices in Berlin, London and Taiwan.
Read more
Category exited technology

Blendle

Blendle wants to make the best journalism accessible to anyone, anywhere, anytime. Users have access to a personalized news offering from premium publishers, and can either pay per article or through a unique subscription. The Dutch start-up was founded two and a half years ago and now has over 1,000,000 users, the majority of them aged under 35. Blendle currently has more than 80 employees, including 15 journalists. In addition to Inkef Capital, media companies The New York Times Company, Nikkei/Financial Times and Axel Springer are among its investors.
Category exited technology

Onefit

Founded in 2012 OneFit offers a market-leading subscription service that allows users to attend any local fitness class or gym for a flat monthly fee. Users have access to the largest network of boutique gyms and studios in the Netherlands. More than 15,000 yoga, spinning, pilates, kickboxing, crossfit, fitness classes and many others are bookable on a weekly basis through a unique one-click experience. OneFit members join these group workouts or check in for individual training at over 600 different studios and gyms. OneFit has been experiencing significant traction and is on its way to European category leadership.
Category exited technology

Wercker

Wercker is a continuous delivery platform focusing on changing the way developers build and deploy their applications. Our platform was built in order to make developers’ lives easier and enabling them to move fast and make things. Team wercker consists of engineers and designers who have previously worked on OpenStack, Google AppEngine, Simple, Digg and Disqus with offices in Amsterdam and San Francisco
Category exited healthcare

NightBalance

NightBalance is a medical device company founded in 2009 and based in Delft, the Netherlands. The company develops and commercializes the Sleep Position Trainer, a proprietary, highly advanced and easy to use device to treat positional obstructive sleep apnea.
Category exited healthcare

Lanthio Pharma

Lanthio Pharma is a Dutch biopharmaceutical company committed to developing and commercializing lanthipeptides as innovative drugs for treating medical conditions. One lanthipeptide has already been out-licensed and several others are in earlier development and discovery stages for important medical indications like fibrosis and cardiovascular diseases.
Category exited healthcare

Sapiens

Founded in 2011, Sapiens is a Dutch developer of deep brain stimulation (DBS) technologies, an advanced treatment that targets degenerative or functional brain disorders such as Parkinson’s disease and dystonia. With offices in Eindhoven, the Netherlands and Munich, Germany, the company’s high-resolution probe reduces stimulation-induced side effects by precisely steering the tiny stimulation currents to the intended target area. Products like SureSuite®, SurePlan®, SurePlace® and SureTune® provide an integrated, image-based solution for planning and programming optimal DBS treatment. SureStim®, the Sapiens implant, is MRI-conditionally safe, and controls the steering.
Category exited healthcare

ProFibrix

ProFibrix is a Dutch biotech company that creates, develops, and markets products for the haemostasis and regenerative medicine markets. It offers its products based on human fibrinogen, a natural blood protein for haemostasis, blood clotting and tissue repair and healing. Its main product is Fibrocaps™, a ready-to-use haemostat and tissue sealant that stop acute and severe bleeding during surgery.